2024-11-0920170363-976210.1097/RLU.00000000000016172-s2.0-85015658830http://dx.doi.org/10.1097/RLU.0000000000001617https://hdl.handle.net/20.500.14288/15688We aimed to emphasize how useful PSMA PET/CT findings can be while trying to restage prostate cancer after radical prostatectomy in the presence of low prostate-specific antigen values. A 64-year-old man with pT3b N1 M0 Gleason 7 adenocarcinoma of the prostate presented 5 years postoperatively with a palpable axillary mass, whereas his prostate-specific antigen was 0.08 ng/mL. Conventional imaging studies and histopathologic findings of the axillary mass biopsy revealed inconclusive results. Ga-68-PSMA PET/CT demonstrated PSMA-positive metastatic lesions, the largest one being located in the right axilla. This finding confirmed metastatic poorly differentiated prostate cancer, and androgen deprivation therapy was initiated.RadiologyNuclear medicineMedical imagingThe utility of ga-68-psma pet/ct in poorly differentiated metastatic prostate cancerOther1536-0229399411600039Q12048